Trinity Biotech plc

TRIB · NASDAQ · Healthcare / Medical Devices

6.10USD+0.22 (+3.74%)

Price History

Full chart

Market Stats

Previous Close5.88

Open5.75

Day Range5.52 – 6.10

52-Week Range6.62 – 52.50

Volume3.42K

Market Cap5.50M

P/E (TTM)0.00

Forward P/E4.54

EPS-60.00

Dividend Yield0.00%

Beta0.97

50-Day Avg9.95

200-Day Avg18.05

About

Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. In addition, the company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. It has a collaboration agreement with a bioinformatics company to conduct analysis on clinical trial data for EpiCapture, a molecular diagnostics company for developing a non invasive urine based prognostic test for progression to aggressive prostate cancer. It has a strategic collaboration agreement with Echelon Data Centres to develop advanced liquid cooling solutions for AI infrastructure. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. John Gillard
Employees287
HeadquartersIDA Business Park, Bray, Ireland, A98 H5C8, USA
Websitehttps://www.trinitybiotech.com

Leadership

Mr. John GillardPresident, CEO, Company Secretary & Director · b. 1981
Mr. Ronan O'Caoimh A.C.A.Founder, Director & Executive Advisor · b. 1956

Financials

Income Statement

Currency: USD	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.40M	5.20M	9.90M	7.20M	16.80M	23.20M	26.10M	29.74M	37.06M	51.98M	65.68M	79.94M	98.56M	118.67M	143.62M	140.14M	125.91M	89.64M	77.95M	82.51M	91.22M	104.87M	100.19M	99.61M	99.14M	97.03M	90.44M	101.98M	81.15M	62.52M	56.83M	61.55M	43.78M
Growth (%)	-	+116.67%	+90.38%	-27.27%	+133.33%	+38.10%	+12.52%	+13.94%	+24.62%	+40.24%	+26.35%	+21.73%	+23.29%	+20.41%	+21.02%	-2.42%	-10.16%	-28.81%	-13.04%	+5.85%	+10.55%	+14.97%	-4.46%	-0.58%	-0.47%	-2.12%	-6.80%	+12.77%	-20.43%	-22.96%	-9.10%	+8.31%	-28.87%
Cost of Revenue	2.20M	4.40M	7.70M	5.50M	10.90M	14.40M	13.02M	13.44M	18.15M	26.37M	32.88M	39.69M	51.38M	67.89M	88.37M	77.64M	68.89M	45.69M	37.82M	40.26M	45.30M	54.52M	53.95M	56.52M	57.25M	55.59M	52.31M	53.40M	54.89M	52.73M	37.38M	40.11M	26.90M
Gross Profit	200.00K	800.00K	2.20M	1.70M	5.90M	8.80M	13.09M	16.30M	18.92M	25.61M	32.80M	40.26M	47.18M	50.78M	55.25M	62.49M	57.02M	43.95M	40.13M	42.25M	45.91M	50.35M	46.24M	43.09M	41.89M	41.45M	38.12M	48.58M	33.45M	22.05M	19.45M	21.44M	16.89M
Gross Margin	8.33%	15.38%	22.22%	23.61%	35.12%	37.93%	50.13%	54.81%	51.04%	49.27%	49.94%	50.36%	47.87%	42.79%	38.47%	44.59%	45.28%	49.03%	51.48%	51.21%	50.33%	48.01%	46.15%	43.26%	42.25%	42.72%	42.15%	47.64%	41.23%	35.26%	34.22%	34.83%	38.57%
Operating Expense	4.40M	3.50M	4.00M	2.40M	5.40M	5.90M	7.92M	9.80M	16.74M	19.15M	23.13M	34.52M	40.56M	48.84M	84.62M	142.07M	42.92M	29.92M	24.34M	25.09M	28.04M	32.31M	32.80M	35.60M	36.41M	38.15M	37.25M	48.50M	29.52M	37.32M	46.49M	42.61M	28.30M
Operating Income	-4.20M	-2.70M	-1.80M	-700.00K	500.00K	2.90M	5.17M	6.50M	2.18M	6.46M	9.67M	5.74M	6.62M	1.94M	-29.37M	-79.58M	14.10M	14.03M	15.78M	17.17M	17.87M	18.04M	13.45M	7.49M	5.48M	3.30M	872.00K	82.00K	3.94M	-15.27M	-27.05M	-21.16M	-11.42M
Operating Margin	-175.00%	-51.92%	-18.18%	-9.72%	2.98%	12.50%	19.79%	21.86%	5.88%	12.42%	14.72%	7.18%	6.72%	1.64%	-20.45%	-56.78%	11.20%	15.65%	20.25%	20.80%	19.59%	17.20%	13.42%	7.52%	5.53%	3.40%	0.96%	0.08%	4.85%	-24.42%	-47.59%	-34.38%	-26.07%
EBITDA	-4.00M	-2.50M	-1.60M	-500.00K	1.60M	3.70M	6.67M	9.78M	8.69M	10.27M	11.89M	8.63M	10.86M	8.36M	-20.99M	-71.47M	14.11M	15.38M	20.80M	22.28M	19.01M	19.93M	19.15M	-30.92M	-29.27M	-13.98M	-19.52M	3.19M	10.59M	-16.71M	-24.10M	-16.91M	-21.38M
EBITDA Margin	-166.67%	-48.08%	-16.16%	-6.94%	9.52%	15.95%	25.55%	32.88%	23.45%	19.75%	18.11%	10.80%	11.02%	7.05%	-14.62%	-51.00%	11.20%	17.16%	26.69%	27.00%	20.84%	19.01%	19.11%	-31.04%	-29.52%	-14.41%	-21.59%	3.13%	13.05%	-26.73%	-42.40%	-27.46%	-48.83%
Net Income	-3.40M	-3.30M	-800.00K	-900.00K	1.20M	2.60M	4.92M	4.82M	1.45M	5.01M	5.80M	5.17M	5.28M	3.28M	-35.37M	-77.78M	11.82M	60.42M	15.59M	17.34M	10.34M	17.21M	21.80M	-100.63M	-40.27M	2.39M	-4.07M	-6.39M	875.00K	-41.00M	-24.02M	-31.79M	-37.38M
Net Income Margin	-141.67%	-63.46%	-8.08%	-12.50%	7.14%	11.21%	18.83%	16.22%	3.91%	9.64%	8.83%	6.46%	5.36%	2.76%	-24.63%	-55.50%	9.39%	67.40%	20.00%	21.02%	11.33%	16.41%	21.75%	-101.02%	-40.62%	2.46%	-4.50%	-6.26%	1.08%	-65.58%	-42.26%	-51.64%	-85.36%
R&D	-	1.00M	1.50M	1.40M	1.80M	2.60M	2.45M	2.68M	2.78M	4.47M	5.21M	4.64M	6.07M	6.70M	13.71M	7.54M	7.34M	4.60M	3.21M	3.13M	3.69M	4.29M	5.07M	5.04M	5.66M	5.37M	5.33M	5.08M	4.50M	4.14M	4.38M	4.54M	3.63M
R&D as % of Total Revenue	-	19.23%	15.15%	19.44%	10.71%	11.21%	9.38%	9.01%	7.50%	8.60%	7.93%	5.81%	6.16%	5.64%	9.55%	5.38%	5.83%	5.14%	4.11%	3.79%	4.05%	4.09%	5.06%	5.06%	5.71%	5.53%	5.89%	4.98%	5.54%	6.62%	7.71%	7.38%	8.29%
Interest Expense	-	900.00K	1.00M	200.00K	900.00K	500.00K	404.33K	704.85K	472.28K	705.63K	792.35K	824.00K	1.06M	2.65M	3.15M	2.16M	1.19M	495.00K	12.00K	88.00K	75.00K	132.00K	3.48M	4.73M	5.41M	5.08M	5.58M	6.75M	7.10M	24.73M	10.15M	9.56M	13.11M
Interest Expense % of Total Revenue	-	17.31%	10.10%	2.78%	5.36%	2.16%	1.55%	2.37%	1.27%	1.36%	1.21%	1.03%	1.07%	2.24%	2.19%	1.54%	0.95%	0.55%	0.02%	0.11%	0.08%	0.13%	3.48%	4.74%	5.45%	5.24%	6.17%	6.62%	8.75%	39.56%	17.86%	15.54%	29.95%

Balance Sheet

Currency: USD	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	4.90M	3.10M	9.20M	13.40M	24.60M	45.00M	45.04M	67.23M	77.03M	89.27M	118.09M	150.83M	184.60M	249.13M	215.98M	129.51M	132.44M	160.87M	171.50M	197.41M	226.49M	242.84M	358.96M	249.59M	192.62M	151.24M	131.07M	130.40M	118.89M	92.10M	59.44M	103.29M	105.17M
Total Liabilities	1.80M	1.80M	1.70M	2.80M	17.50M	30.40M	22.32M	12.19M	20.50M	26.36M	37.83M	34.69M	50.98M	81.87M	79.13M	63.60M	53.10M	19.59M	20.17M	28.03M	43.48M	45.87M	145.07M	140.87M	127.42M	107.18M	126.36M	132.62M	119.21M	94.28M	83.38M	138.47M	177.15M
Total Equity	2.40M	1.30M	7.50M	10.60M	7.10M	14.60M	22.95M	55.04M	56.22M	62.91M	80.26M	116.14M	133.62M	167.26M	136.84M	65.91M	79.34M	141.29M	151.33M	169.38M	183.01M	196.97M	213.89M	108.73M	65.20M	44.05M	4.71M	-2.22M	-319.00K	-2.18M	-23.95M	-35.18M	-71.98M
Cash	900.00K	300.00K	7.50M	4.90M	2.80M	1.30M	3.06M	4.28M	5.28M	5.77M	20.56M	22.29M	4.92M	2.82M	8.70M	5.18M	6.08M	58.00M	71.08M	74.95M	22.32M	9.10M	101.95M	77.11M	57.61M	30.28M	16.40M	27.33M	25.91M	6.58M	3.69M	5.17M	5.14M
Total Debt	200.00K	200.00K	100.00K	-	200.00K	11.90M	12.67M	3.76M	9.88M	7.75M	22.21M	22.79M	27.13M	50.98M	42.13M	36.18M	31.91M	273.00K	118.00K	3.32M	-	-	98.04M	96.76M	95.18M	82.06M	102.17M	104.34M	99.16M	72.20M	67.43M	100.76M	137.98M
Net Debt	-700.00K	-100.00K	-7.40M	-4.90M	-2.60M	10.60M	9.60M	-520.50K	4.60M	1.98M	1.65M	501.00K	22.21M	48.16M	33.43M	31.00M	25.84M	-57.73M	-70.97M	-74.95M	-22.32M	-9.10M	-3.91M	19.38M	37.22M	51.34M	65.63M	77.01M	73.25M	51.68M	63.74M	95.60M	132.84M

Cash Flow

Currency: USD	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-2.40M	-3.10M	-800.00K	-3.60M	-1.40M	-1.00M	3.82M	3.02M	5.06M	11.65M	3.60M	42.00K	9.21M	7.37M	15.35M	10.73M	14.73M	23.07M	20.48M	20.06M	11.71M	15.75M	12.34M	13.77M	12.11M	6.93M	5.47M	23.75M	13.24M	-921.00K	-11.56M	-4.19M	-5.93M
Investing Cash Flow	100.00K	-	1.20M	-3.00M	-	-10.00M	-6.23M	-	-7.42M	-	-10.84M	-26.04M	-24.40M	-63.27M	-8.41M	-14.69M	-10.34M	56.88M	841.00K	-7.63M	-59.96M	-23.94M	-22.72M	-22.28M	-16.37M	-17.29M	-15.36M	-10.20M	-8.69M	-5.98M	24.76M	-22.97M	-6.22M
Financing Cash Flow	500.00K	2.40M	6.80M	4.00M	8.90M	8.90M	3.84M	13.91M	988.86K	5.06M	6.69M	29.65M	9.68M	48.62M	-1.11M	481.00K	-3.51M	-27.98M	-8.24M	-8.57M	-4.37M	-5.03M	103.23M	-16.34M	-15.25M	-16.98M	-4.00M	-2.72M	-6.02M	-12.32M	-16.04M	28.81M	12.05M
Capital Expenditure	800.00K	100.00K	100.00K	2.50M	8.10M	2.80M	1.45M	1.17M	1.34M	2.52M	3.86M	3.69M	4.04M	10.84M	16.11M	12.69M	10.58M	9.02M	9.23M	12.92M	21.95M	23.94M	22.72M	22.28M	16.37M	17.29M	15.36M	10.20M	8.69M	5.98M	803.00K	10.06M	6.22M
Free Cash Flow	-3.20M	-3.20M	-900.00K	-6.10M	-9.50M	-3.80M	2.38M	1.85M	3.72M	9.14M	-251.55K	-3.65M	5.17M	-3.47M	-764.00K	-1.97M	4.15M	14.06M	11.25M	7.14M	-10.24M	-8.19M	-10.38M	-8.51M	-4.25M	-10.35M	-9.88M	13.56M	4.55M	-6.90M	-12.36M	-14.26M	-12.15M
Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.15M	3.22M	4.37M	5.03M	5.10M	5.17M	0	0	0	0	0	0	0	0	0
FCF to OCF	133.33%	103.23%	112.50%	169.44%	678.57%	380.00%	62.17%	61.15%	73.46%	78.40%	-6.98%	-8683.33%	56.14%	-47.07%	-4.98%	-18.31%	28.16%	60.92%	54.92%	35.58%	-87.47%	-51.96%	-84.16%	-61.77%	-35.13%	-149.26%	-180.51%	57.07%	34.35%	748.97%	106.95%	340.13%	204.96%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19.10%	45.17%	-42.71%	-61.45%	-49.12%	-60.84%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Earnings

Report Date	Feb 11, 1999	Mar 31, 2001	Jun 30, 2001	Sep 30, 2001	Dec 31, 2001	Mar 31, 2002	Jun 30, 2002	Sep 30, 2002	Feb 13, 2003	Jul 23, 2003	Oct 23, 2003	Feb 17, 2004	Apr 28, 2004	Jul 28, 2004	Oct 20, 2004	Feb 22, 2005	Apr 28, 2005	Jul 28, 2005	Oct 27, 2005	Mar 6, 2006	Apr 27, 2006	Aug 9, 2006	Oct 26, 2006	Mar 6, 2007	Apr 26, 2007	Aug 9, 2007	Oct 25, 2007	Mar 14, 2008	Apr 29, 2008	Jul 22, 2008	Oct 31, 2008	Mar 10, 2009	Apr 29, 2009	Jul 23, 2009	Oct 21, 2009	Mar 11, 2010	May 11, 2010	Jul 29, 2010	Oct 20, 2010	Mar 3, 2011	May 5, 2011	Jul 21, 2011	Oct 20, 2011	Mar 5, 2012	Apr 19, 2012	Jul 12, 2012	Oct 18, 2012	Mar 5, 2013	Apr 25, 2013	Jul 30, 2013	Oct 17, 2013	Mar 4, 2014	Apr 29, 2014	Jul 29, 2014	Oct 23, 2014	Mar 3, 2015	Apr 30, 2015	Jul 28, 2015	Oct 22, 2015	Mar 3, 2016	Apr 19, 2016	Jul 21, 2016	Oct 25, 2016	Mar 14, 2017	Apr 27, 2017	Jul 20, 2017	Oct 26, 2017	Mar 7, 2018	May 1, 2018	Jul 19, 2018	Oct 23, 2018	Mar 7, 2019	May 7, 2019	Aug 20, 2019	Oct 16, 2019	Mar 31, 2020	May 27, 2020	Aug 25, 2020	Nov 17, 2020	Mar 25, 2021	May 25, 2021	Sep 9, 2021	Dec 15, 2021	Mar 23, 2022	Jun 30, 2022	Jul 21, 2022	Dec 15, 2022	Mar 23, 2023	May 2, 2023	Jul 6, 2023	Oct 3, 2023	Jan 31, 2024	Apr 4, 2024	Aug 14, 2024	Nov 15, 2024	Dec 31, 2024	May 16, 2025	Jul 1, 2025	Dec 23, 2025	Apr 8, 2026
EPS Estimate	0.12	-	-	-	-	-	-	-	18.00	0.16	0.16	0.16	30.00	24.00	12.00	-	16.20	8.25	2.85	10.65	-	0.35	22.50	-	18.00	21.00	21.00	0.09	16.50	12.00	12.00	0.07	10.50	15.00	18.00	0.13	18.00	16.35	19.65	20.80	0.15	24.38	25.95	0.17	25.50	28.50	31.50	0.21	27.75	29.25	31.50	0.21	28.88	30.00	30.00	0.19	25.88	20.40	13.75	0.09	12.00	9.75	12.30	-0.80	4.50	7.50	8.50	0.07	7.50	9.00	9.00	0.04	10.50	0.07	9.00	9.00	0.03	-0.02	15.00	21.00	0.07	10.50	12.00	0.07	-6.00	-0.03	-6.00	-9.00	-0.06	-9.00	-13.50	-0.14	-0.12	-19.50	-16.20	-9.00	-0.05	-17.10	0.00	-
EPS Actual	0.12	18.83	18.62	21.04	-31.41	18.19	17.01	18.07	24.00	0.16	0.16	0.12	7.80	12.60	15.24	19.30	10.80	12.60	16.50	13.80	12.10	0.60	81.00	13.29	22.50	21.00	3.00	0.06	8.25	10.95	9.45	0.07	18.00	21.60	21.75	0.15	22.20	22.65	24.30	24.90	0.17	25.95	26.55	0.18	27.90	28.80	29.70	0.20	28.50	26.40	29.70	0.19	27.30	27.30	27.60	0.18	25.50	14.85	14.55	0.11	4.35	8.25	13.50	0.22	1.18	4.65	9.85	0.08	5.10	4.35	1.95	0.07	0.75	0.04	0.75	13.50	0.05	-5.40	53.70	53.85	0.10	30.45	9.30	-0.06	-11.73	-0.03	-7.70	-27.75	-0.06	-24.78	-30.12	-0.17	-3.59	-14.00	-12.77	-26.35	-1.24	-14.40	-0.40	-28.12
Surprise	0.00%	-	-	-	-	-	-	-	33.33%	0.00%	0.00%	-25.00%	-74.00%	-47.50%	27.00%	-	-33.33%	52.73%	478.95%	29.58%	-	71.43%	260.00%	-	25.00%	0.00%	-85.71%	-33.33%	-50.00%	-8.75%	-21.25%	0.00%	71.43%	44.00%	20.83%	15.38%	23.33%	38.53%	23.66%	19.71%	13.33%	6.44%	2.31%	5.88%	9.41%	1.05%	-5.71%	-4.76%	2.70%	-9.74%	-5.71%	-9.52%	-5.47%	-9.00%	-8.00%	-5.26%	-1.47%	-27.21%	5.82%	22.22%	-63.75%	-15.38%	9.76%	127.50%	-73.78%	-38.00%	15.88%	14.29%	-32.00%	-51.67%	-78.33%	75.00%	-92.86%	-42.86%	-91.67%	50.00%	76.67%	-26900.00%	258.00%	156.43%	42.86%	190.00%	-22.50%	-185.71%	-95.50%	0.00%	-28.33%	-208.33%	0.00%	-175.33%	-123.11%	-25.00%	-2890.67%	28.21%	21.17%	-192.75%	-2380.00%	15.79%	-	-
Timing	-	-	-	-	-	-	-	-	Pre-market	-	-	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	After-hours	Pre-market	Pre-market	-	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	-	Pre-market	-	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	-	Pre-market	-	-

Key Statistics & Ratios

Market Cap5.50M

Enterprise Value138.86M

Trailing P/E0.00

Forward P/E4.54

PEG Ratio0.30

Price / Sales0.13

Price / Book5.75

EPS-60.00

Book Value-115.42

Revenue (TTM)43.78M

Gross Profit (TTM)16.89M

EBITDA-8.24M

Profit Margin-85.36%

Operating Margin-9.98%

Return on Equity-1913.45%

Return on Assets-5.72%

Shares Outstanding813.13K

Shares Float555.43K

Beta0.97

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Strong Buy

Based on 1 analystsTarget 3.00

Strong Buy
1

Ownership Breakdown

Institutions: 4.07%
Insiders: 13.81%
Retail / Other: 82.12%

Top Institutional Holders

Hunter Associates Inc.
661.21K2.71%
Williams & Novak LLC
140.54K0.58%
Virtu Financial LLC
26.68K0.11%
Moss Adams Wealth Advisors LLC
25.67K0.11%
Integrys Wealth Advisors LLC
25.00K0.10%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
22.28K0.09%
Becker Capital
18.00K0.07%
Renaissance Technologies Corp
17.76K0.07%
Geode Capital Management, LLC
16.64K0.07%
LPL Financial Corp
15.04K0.06%
Rhumbline Advisers
5.55K0.02%
JONES FINANCIAL COMPANIES LLLP
3.80K0.02%
Wells Fargo & Co
2.50K0.01%
UBS Group AG
1.01K0.00%
SIMPLEX TRADING, LLC
5550.00%
Morgan Stanley - Brokerage Accounts
4020.00%
Atwood & Palmer Inc
200.00%
Mcilrath & Eck, LLC
50.00%
Triumph Capital Management
00.00%

Top Fund Holders

Fidelity Nasdaq Composite Index
4190.05%

Dividends

20151×

33.00Jun 5, 2015

20141×

33.00Jun 6, 2014

20131×

30.00Jun 6, 2013

20121×

22.50Jun 6, 2012

20111×

15.00Jun 7, 2011

Stock Splits

Jul 24, 20261:30
Feb 23, 20241:5
Jun 2, 20051:4